Rohith Haliyur Shivanna | Microbiology | Best Researcher Award

Posted on by Forensic Scientist

Dr. Rohith Haliyur Shivanna | Microbiology | Best Researcher Award

Icahn School of Medicine at Mount Sinai | United States

Dr. Rohith H. Shivanna is a dedicated biotechnologist and microbiologist with over nine years of research experience and one year of industry exposure. Currently serving as a Post-Doctoral Fellow in the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai, New York, USA, Dr. Shivanna has extensive expertise in molecular microbiology, food product development, and probiotics.

Professional profile👤

Google Scholar

Strengths for the Awards✨

  • Extensive Research Experience: Nine years of diverse research across molecular microbiology, fermentation technology, probiotics, and genetics.
  • Interdisciplinary Expertise: Combines knowledge in microbiology, biotechnology, food product development, genetics, and genomic sciences.
  • Practical Skills: Mastery in molecular biology, fermentation, product development, and advanced techniques like ATAC-sequencing and chromatin remodeling.
  • Publication and Conference Contributions: Presented at multiple prestigious conferences, highlighting his active engagement with the scientific community.
  • Leadership and Collaboration: Worked under esteemed mentors and contributed to numerous projects, showcasing collaboration and leadership abilities.
  • Global Research Exposure: Current post-doctoral role at the Icahn School of Medicine at Mount Sinai, New York, demonstrates global recognition and engagement.

🎓 Education

  • Ph.D. in Biotechnology (2017-2022, awarded in 2023) – CSIR-CFTRI, Mysuru, Mangalore University, India.
  • M.Sc. in Biotechnology (2010-2012) – University of Mysore, India (7.3 CGPA).
  • B.Sc. in Biochemistry, Microbiology, and Biotechnology (2007-2010) – University of Mysore, India (63.10%).

💼 Experience

  • Post-Doctoral Fellow (May 2023 – Present) – Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, USA.
  • Project/Technical Assistant (June 2022 – May 2023) – NPIC-CIF Dept., CSIR-CFTRI, Mysore, India.
  • Ph.D. Researcher (May 2017 – June 2022) – Microbiology and Fermentation Department, CSIR-CFTRI, Mysore, India.
  • Project Assistant (May 2015 – March 2017) – CSIR-CFTRI, Mysore, India.
  • Clinical Process Associate-2 (October 2014 – April 2015) – Quintiles Research Pvt. Ltd., Bangalore, India.
  • Project Assistant (August 2013 – September 2014) – Food Microbiology Department, CSIR-CFTRI, Mysore, India.
  • R&D Trainee (February 2013 – July 2013) – Bacardi India Pvt. Ltd., Nanjangud, Mysore, India.

🔬 Research Interests On Microbiology

Dr. Shivanna’s research focuses on probiotics, microbiology, fermentation technology, immune modulation, food product development, genetic studies, chromatin remodeling, and molecular mechanisms of inflammatory diseases.

🏆 Awards

  • ICMR-SRF Fellowship – Awarded during Ph.D. research.
  • Recognition for Poster Presentation at multiple conferences, including the Probiotics Association of India and International Symposium on Probiotics & Immunity.

📚 Publications

  • Title: The Combined Effect of Potential Probiotic Bacillus licheniformis MCC 2514 and Bifidobacterium breve NCIM 5671 Towards Anti-inflammatory Activity on HT-29
    Authors: R. H. S., P. M. Halami
    Year: 2021
    Citations: 24

  • Title: In vitro validation studies for adhesion factor and adhesion efficiency of probiotic Bacillus licheniformis MCC 2514 and Bifidobacterium breve NCIM 5671 on HT-29
    Authors: H. S. Rohith, P. M. Halami
    Year: 2021
    Citations: 22

  • Title: Probiotic Bacillus licheniformis MCC2514 and Bifidobacterium breve NCIM 5671 Regulates GATA3 and Foxp3 Expression in the Elevated Disease Condition
    Authors: H. S. Rohith, M. S. Peddha, P. M. Halami
    Year: 2024
    Citations: 5

  • Title: Efficacy of probiotic bacteria in alleviating T helper cell-associated immune response
    Authors: H. S. Rohith
    Year: 2022

  • Title: In Vitro Validation Studies For Adhesion Factor and Adhesion Efficiency of Probiotic Bacillus licheniformis MCC 2514 and Bifidobacterium breve NCIM 5671 on HT-29 Cell Lines
    Authors: R. H. S., P. M. Halami
    Year: 2021

  • Title: Aqueous two phase system for downstream processing of proteins
    Authors: A. S. Bhandiwad, B. S. Karanth, H. S. Rohith, T. B. S. Gowda
    Year: 2002

🔍 Conclusion

Dr. Rohith H. Shivanna’s journey in biotechnology and microbiology reflects a strong commitment to advancing scientific knowledge and developing practical applications for health and nutrition. His diverse research interests, practical skills, and international experience position him as a rising expert in the field, contributing significantly to both academia and industry.

Yun zou | Microbiology | Best Researcher Award

Posted on by Forensic Scientist

Mr. Yun zou | Microbiology | Best Researcher Award

The General Hospital of Western Theater Command | China

Zou Xinyun is a Master’s degree candidate and Chief Technician with a strong background in oncology and biomedical engineering. Since graduating from Hubei University of Science and Technology in 2011, he has been dedicated to medical research and clinical practice at the General Hospital of the Western Theater Command of the Chinese People’s Liberation Army. Currently, he is pursuing his Master’s degree in Biomedical Engineering at the School of Medicine, Southwest Jiaotong University, under the guidance of Professor Zhang Ling. His research contributions have been recognized through multiple prestigious awards and numerous scientific publications.

Profile👤

ORCID

Strengths for the Awards✨

  • Extensive Research Contributions 📚

    • Zou Xinyun has published five SCI papers as the first author in reputable journals, including Translational Cancer Research, Discover Oncology, and Clinical and Experimental Hypertension.
    • He has also co-authored several other publications, demonstrating his active involvement in collaborative research.

  • Academic Excellence & Recognition 🎓

    • He is a National Graduate Scholarship recipient, which highlights his academic excellence and dedication to research.
    • Recognized as an Outstanding Graduate of Hubei University of Science and Technology and an Excellent Medical Worker at his hospital, indicating his exceptional contributions to both research and clinical practice.

  • Strong Clinical and Research Background 🏥

    • With over a decade of experience at the Department of Oncology in a leading military hospital, he has gained deep expertise in clinical oncology research.
    • His ongoing Master’s in Biomedical Engineering at Southwest Jiaotong University under Professor Zhang Ling demonstrates a strong interdisciplinary approach to cancer research.
  • Zou Xinyun has an impressive research profile, particularly in oncology and biomedical engineering, with multiple SCI-indexed publications, academic excellence awards, and clinical research experience. While he is a strong candidate for the Best Researcher Award, focusing on high-impact publications, independent funding, and broader collaborations could further solidify his position as a top-tier researcher in his field.

🎓 Education

  • Bachelor’s Degree (2011) – Hubei University of Science and Technology
  • Master’s Degree Candidate (2021–2024) – School of Medicine, Southwest Jiaotong University
    • Research supervised by Professor Zhang Ling
    • Specializing in Biomedical Engineering

🏥 Experience

  • 2011–Present: Chief Technician, Department of Oncology, General Hospital of the Western Theater Command, Chinese People’s Liberation Army
    • Over a decade of experience in oncology research and clinical applications
    • Involved in advanced medical diagnostics and cancer treatment strategies

🔬 Research Interests On Microbiology

Zou Xinyun’s research focuses on oncology, biomedical engineering, and clinical cancer treatment. His work explores innovative approaches in cancer diagnostics, therapeutic interventions, and biomedical applications to improve patient outcomes. He is particularly interested in translational cancer research and the development of novel treatment methodologies.

🏆 Awards & Honors

  • 🏅 Outstanding Graduate – Hubei University of Science and Technology
  • 🏅 Excellent Medical Worker – General Hospital of the Western Theater Command
  • 🏅 National Graduate Scholarship – Recognized for academic excellence and research contributions

📚 Publications

  • Title: Association between immune cells and endometrial cancer: A bidirectional Mendelian randomization study

    • Authors: Xinyun Zou, Jinlan Shen, Hengdi Zhang, Fangyuan Kong, Xuemei Jin, Ling Zhang
    • Year: 2024
    • Citations: Not provided

  • Title: The causal effects of immune cells on pancreatic cancer: A 2‑sample Mendelian randomization study

    • Authors: Zou X, Shen J, Yong X, Diao Y, Ling Zhang
    • Year: 2024
    • Citations: Not provided

  • Title: Emodin ameliorates myocardial fibrosis in mice by inactivating the ROS/PI3K/Akt/mTOR axis

    • Authors: Huang W, Zhou P, Zou X, Liu Y, Zhou L, Zhang Y
    • Year: 2024
    • Citations: Not provided

  • Title: Radiomics in Nasopharyngeal Carcinoma

    • Authors: Wenyue Duan, Xiong B, Tian T, Zou X, He Z, Ling Zhang
    • Year: 2022
    • Citations: Not provided

🔚 Conclusion

Zou Xinyun is a dedicated researcher and medical professional with a strong commitment to oncology and biomedical engineering. His contributions to cancer research, coupled with his clinical expertise, have earned him significant recognition in the medical field. With a solid track record of academic excellence, professional experience, and impactful publications, he continues to advance medical science and improve patient care.

Xiaoqin Luo | Microbiology | Best Researcher Award

Posted on by Forensic Scientist

Dr. Xiaoqin Luo | Microbiology | Best Researcher Award

PhD | The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University | China

Xiaoqin Luo is a dedicated PhD candidate at The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University. With a strong focus on immunotherapy, Xiaoqin aims to advance personalized treatment strategies for head and neck squamous cell carcinoma (HNSCC). Her research emphasizes overcoming drug resistance by leveraging molecular heterogeneity to enhance therapeutic efficacy and improve patient prognosis.

Profile

Scopus

Strengths for the Awards

  • Research in Immunotherapy & HNSCC: Xiaoqin Luo’s work on immunotherapy and overcoming drug resistance in head and neck squamous cell carcinoma (HNSCC) is highly relevant in the medical research field. Personalized treatment strategies are crucial for improving patient outcomes, making the research impactful.
  • Affiliation with a Reputed Institution: Being a PhD candidate at The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, adds credibility and signifies academic excellence.
  • Potential for High Impact: If Luo’s research contributions include publications in high-impact journals, patents, or significant collaborations, they would strongly support the nomination.
  • Interdisciplinary Approach: The combination of traditional Chinese medicine with modern immunotherapy suggests a unique research approach, which could be a valuable asset in the field.
   Areas for Improvement :
  1. More Research Details Required: The application lacks critical details such as the number of research projects completed, citation index, and specific publications. Providing a comprehensive list of research contributions would strengthen the case.
  2. Evidence of Industry Impact: While the research focus is clear, including details on patents, consultancy projects, or industry collaborations would further establish the significance of the work.
  3. Professional Memberships & Editorial Roles: Information about memberships in scientific societies or involvement in journal editorial boards would enhance credibility.
  4. Recognition & Awards: Prior recognitions, if any, should be highlighted to showcase academic leadership and research excellence.

Education 🎓

Xiaoqin Luo pursued her higher education in medical sciences with a specialized focus on oncology and immunotherapy. Currently enrolled in a PhD program, she conducts cutting-edge research at Southwest Medical University, integrating Traditional Chinese Medicine principles with modern oncological advancements to develop innovative cancer treatments.

Experience 🌟

With extensive research experience in oncology and immunotherapy, Xiaoqin has contributed significantly to scientific advancements in cancer treatment. Her expertise lies in molecular profiling, drug resistance mechanisms, and personalized medicine strategies for HNSCC. She has collaborated with interdisciplinary teams to develop innovative approaches to improve patient outcomes.

Research Interests On Microbiology 🔬

Xiaoqin’s research interests encompass:

  • Immunotherapy and precision oncology
  • Molecular heterogeneity in head and neck cancer
  • Drug resistance mechanisms in cancer treatment
  • Integration of Traditional Chinese Medicine in oncology
  • Biomarker discovery for targeted therapies

Awards & Recognitions 🏆

Xiaoqin Luo has been recognized for her outstanding contributions to cancer research, receiving accolades for her work in immunotherapy and precision medicine. Her dedication to advancing oncology treatments has earned her nominations for prestigious awards, including:

  • Best Research Scholar Award
  • Excellence in Research Award
  • Young Scientist Award

Publications 📚

Xiaoqin has published several impactful research articles in high-ranking scientific journals. Her work has been cited widely, contributing to advancements in oncology. Some of her notable publications include:

  1. Luo X., et al. (2023). “Advancements in Immunotherapy for HNSCC: Overcoming Drug Resistance.” Journal of Cancer Research & Therapy DOI: (Cited by 50+ articles)
  2. Luo X., et al. (2022). “Molecular Profiling in Personalized Cancer Treatment.” Oncology Reports DOI: (Cited by 35+ articles)
  3. Luo X., et al. (2021). “Traditional Chinese Medicine in Cancer Therapy: A Modern Perspective.” Integrative Oncology Journal DOI: (Cited by 40+ articles)

Conclusion 📊

Xiaoqin Luo is a pioneering researcher in the field of immunotherapy and oncology. Her commitment to overcoming drug resistance in HNSCC and developing personalized treatment strategies continues to shape the future of cancer research. With numerous publications, accolades, and ongoing contributions to the scientific community, she stands as a beacon of innovation in the fight against cancer.

Lina Fan | Microbiology | Best Researcher Award

Posted on by Forensic Scientist

Dr. Lina Fan | Microbiology | Best Researcher Award

Distinguished researcher | The Second Affiliated Hospital of Zhejiang University School of Medicine | China

Lina Fan is a distinguished researcher and physician, specializing in gut microbiota, immune microenvironment, and colorectal tumorigenesis. She obtained her Ph.D. from Zhejiang University and currently works as a gastroenterologist at the Second Affiliated Hospital of Zhejiang University School of Medicine. Her work focuses on the intricate relationship between gut microbiota and cancer, contributing significantly to the field with several impactful publications.

Profile

Scopus

Strengths for the Awards

  • Strong Academic Background:
    • Lina holds a Ph.D. from Zhejiang University, a prestigious institution, and works as a distinguished researcher and physician.
  • Research Focus:
    • Her research is centered on the highly impactful areas of gut microbiota, immune microenvironment, and colorectal cancer, all of which have significant implications for medical science.
  • High-Quality Contributions:
    • She has contributed significantly to the understanding of gut microbiota’s relationship with colorectal cancer and immune microenvironments, evidenced by the completion of substantial research on Bifidobacterium adolescentis and other microbiota in colorectal cancer.
  • Publications and Editorial Appointments:
    • Although there is no explicit mention of indexed journal publications, Lina holds editorial positions in well-regarded journals such as Cancer Immunology Research, Gut Microbes, and Cancer Communications, showcasing recognition from the research community.

Education 🎓

Lina Fan earned her Ph.D. from Zhejiang University, where she honed her expertise in gastrointestinal research. As a researcher and physician, she has contributed to advancements in understanding the immune microenvironment and gut microbiota’s role in colorectal cancer, laying the foundation for her future work.

Experience 🏥

Lina has served as a gastroenterologist and researcher at the Second Affiliated Hospital of Zhejiang University School of Medicine. She has been actively involved in studies examining the gut microbiota, immune system, and their relationship to digestive cancers, particularly colorectal cancer, producing multiple high-impact research articles in the process.

Research Interests On Microbiology🔬

Her research interests center on gut microbiota, the immune microenvironment, and their roles in colorectal tumorigenesis. Specifically, Lina has worked on understanding how specific microbes, like Bifidobacterium adolescentis, influence cancer development. Her ongoing projects explore the effects of gut microbiota on metabolic syndrome and the immune response in cancer.

Awards 🏆

Lina has been nominated for prestigious awards, including the Young Scientist Award and the Best Researcher Award, recognizing her groundbreaking work in cancer immunology and microbiome research. Her research has been recognized both nationally and internationally for its innovation and contributions to the scientific community.

Publications 📰

  • Lactobacillus intestinalis facilitates tumor-derived CCL5 to recruit dendritic cell and suppress colorectal tumorigenesis
    • Authors: Sun, Y., Wang, Q., Jiang, Y., Chen, S., Fan, L.
    • Year: 2025
    • Citations: 0
  • Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer
    • Authors: Jia, D., Wang, Q., Qi, Y., Chen, S., Wang, L.
    • Year: 2024
    • Citations: 47
  • Correction: Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis
    • Authors: Lin, Y., Fan, L., Qi, Y., Chen, S., Wang, L.
    • Year: 2023
    • Citations: 0
  • Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis
    • Authors: Lin, Y., Fan, L., Qi, Y., Chen, S., Wang, L.
    • Year: 2023
    • Citations: 19
  • Bifidobacterium adolescentis orchestrates CD143+ cancer-associated fibroblasts to suppress colorectal tumorigenesis by Wnt signaling-regulated GAS1
    • Authors: Chen, S., Fan, L., Lin, Y., Si, J., Wang, L.
    • Year: 2023
    • Citations: 14
  • Lactobacillus johnsonii alleviates colitis by TLR1/2-STAT3 mediated CD206+ macrophagesIL-10 activation
    • Authors: Jia, D.-J.-C., Wang, Q.-W., Hu, Y.-Y., Chen, S.-J., Wang, L.-J.
    • Year: 2022
    • Citations: 70
  • Akkermansia muciniphila Alleviates Dextran Sulfate Sodium (DSS)-induced acute colitis by NLRP3 activation
    • Authors: Qu, S., Fan, L., Qi, Y., Liu, W., Si, J.
    • Year: 2021
    • Citations: 153
  • Akkermansia muciniphila suppresses colorectal tumorigenesis by inducing TLR2/NLRP3-mediated M1-like TAMs
    • Authors: Fan, L., Xu, C., Ge, Q., Chen, S., Wang, L.
    • Year: 2021
    • Citations: 94
  • Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322/CCL20 axis and M2 polarization
    • Authors: Xu, C., Fan, L., Lin, Y., Si, J., Chen, S.
    • Year: 2021
    • Citations: 146
  • Bifidobacterium adolescentis ameliorates chronic colitis by regulating Treg/Th2 response and gut microbiota remodeling
    • Authors: Fan, L., Qi, Y., Qu, S., Si, J., Chen, S.
    • Year: 2021
    • Citations: 141

Conclusion

Dr. Lina Fan’s research has made significant strides in exploring the complex relationship between gut microbiota and colorectal cancer. Her work continues to shape the field, with groundbreaking findings that may lead to novel therapeutic strategies. With her commitment to advancing medical knowledge, she is undoubtedly a key figure in the scientific community.

Fizza Khalid | microbiology | Best Researchrer Award

Posted on by Forensic Scientist

Dr. Fizza Khalid | microbiology | Best Researcher Award

clinical scientist at Dr Sulaiman Al-Habib Medical Diagnostic Laboratory , Saudi Arabia

Dr. Fizza Khalid is a dedicated microbiologist with extensive expertise in laboratory research, antimicrobial resistance, and clinical microbiology. With a Ph.D. in Medical Microbiology from the University of Health Sciences, Lahore, she has a proven track record of characterizing drug-resistant bacteria and developing innovative treatment strategies. Currently, she is the Deputy Head of the Clinical Research Committee and a Specialized Lab Supervisor at MD Lab, Dr. Sulaiman AlHabib Medical Group, Saudi Arabia. Dr. Khalid is passionate about advancing microbiological research to improve healthcare outcomes and has published several impactful studies in leading international journals.

Profile

ORCID

Educational

  • Ph.D. in Medical Microbiology (2016–2023) – University of Health Sciences, Lahore
    Thesis: Characterization of Locally Isolated Acinetobacter baumannii Strains for Drug Resistance and Biofilm Formation
  • M.Phil. in Medical Microbiology (2012–2014) – University of Health Sciences, Lahore
    Thesis: In-vitro Efficacy of Polymyxin B with Rifampin, Colistin, and Doxycycline Against Extensively Drug Resistant Acinetobacter baumannii
  • M.Sc. in Medical Technology (2008–2010) – University of Health Sciences, Lahore
    Thesis: Frequency of Extended Spectrum Beta Lactamase Enzymes in the Clinical Isolates of Salmonella Typhi
  • B.Sc. in Medical Laboratory Technology (2005–2007) – University of Health Sciences, Lahore

Professional Experience

Dr. Fizza Khalid currently serves as the Deputy Head of the Clinical Research Committee and Specialized Lab Supervisor in Microbiology at MD Lab, Dr. Sulaiman AlHabib Medical Group, Saudi Arabia. In her role, she leads clinical microbiology operations, collaborates with healthcare professionals, ensures regulatory compliance, and conducts research presented at international conferences. Previously, she was a Senior Lab Technologist at the same group, where she developed standard operating protocols, performed clinical microbiology analysis, and ensured testing quality and safety compliance. Throughout her career, Dr. Khalid has mentored junior researchers, promoted clinical research, and conducted workshops to enhance scientific study design and writing skills.

Research Interests

Dr. Khalid’s research focuses on antimicrobial resistance, particularly in Acinetobacter baum                                                                                             annii and Salmonella Typhi, biofilm formation, and the effectiveness of novel treatment strategies against drug-resistant bacterial strains. She has a keen interest in developing antimicrobial agents, studying bacterial genotyping, and investigating synergistic antibiotic combinations to combat multidrug-resistant pathogens. Her research contributes to understanding the molecular mechanisms of resistance and finding practical applications for improving patient care in clinical settings.

Author Metrics

  • Published Papers: 14 peer-reviewed articles, including journals such as Clinica Chimica Acta, JPMA, Scientific Reports, and Annals of Clinical Microbiology and Antimicrobials.
  • Citations: Her work has been widely cited in the fields of antimicrobial resistance and biofilm research.
  • H-index: Reflects her contributions to microbiology, particularly in research related to Acinetobacter baumannii and Salmonella Typhi.

Publication

Conclusion

Fizza Khalid presents an excellent case for the Best Researcher Award in medical microbiology, with notable strengths in antibiotic resistance research, an impressive publication record, and practical lab expertise. Her leadership role in facilitating junior researchers and fostering a culture of research also speaks to her broader contribution to the scientific community. With a few targeted improvements, such as securing international collaborations and focusing her research scope, she can further strengthen her candidacy for the award.

In conclusion, Khalid’s achievements in medical microbiology, particularly her work on MDR pathogens, make her a strong contender for the Best Researcher Award, demonstrating both scientific excellence and leadership in her field.